Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

Devin M. Razavi-Shearer*, Ivane Gamkrelidze, Calvin Q. Pan, Jidong Jia, Thomas Berg, Richard T. Gray, Young-Suk Lim, Chien-Jen Chen, Ponsiano Ocama, Hailemichael Desalegn, Zaigham Abbas, Ayat R. Abdallah, Alessio Aghemo, Sabohat Ahmadbekova, Sang Hoon Ahn, Inka Aho, Ulus S. Akarca, Nasser M. Al Masri, Abduljaleel M. Alalwan, Seyed M. AlavianSaid A. Al-Busafi, Soo Aleman, Faleh Z. Alfaleh, Abdullah S. Alghamdi, Waleed K. Al-Hamoudi, Abdulrahman A. Aljumah, Khalid Al-Naamani, Ahmad Al-Rifai, Yousif M. AlSerkal, Ibrahim H. Altraif, Jazag Amarsanaa, Motswedi Anderson, Monique Andersson, Paige Armstrong, Tarik Asselah, Kostas Athanasakis, Oidov Baatarkhuu, Ziv Ben-Ari, Aicha Bensalem, Fernando Bessone, Mia J. Biondi, Abdul Rahman N. Bizri, Sarah Blach, Wornei S. M. Braga, Carlos E. Brandao-Mello, Carol L. Brosgart, Kimberly A. Brown, Robert S. Brown Jr, Philip Bruggmann, Maurizia R. Brunetto, Et al., Sofia de Figueiredo Ribeiro

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study'. Together they form a unique fingerprint.

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology